| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Computational Biology | 24 | 2025 | 872 | 3.050 |
Why?
|
| Mutation, Missense | 11 | 2025 | 929 | 1.650 |
Why?
|
| Genetic Variation | 10 | 2025 | 1556 | 1.280 |
Why?
|
| Genetic Fitness | 6 | 2024 | 34 | 1.020 |
Why?
|
| Tumor Suppressor Protein p53 | 8 | 2024 | 739 | 0.810 |
Why?
|
| Amino Acid Substitution | 6 | 2025 | 410 | 0.800 |
Why?
|
| Phenotype | 16 | 2025 | 4515 | 0.660 |
Why?
|
| Polymorphism, Single Nucleotide | 9 | 2025 | 2862 | 0.630 |
Why?
|
| Evolution, Molecular | 5 | 2019 | 657 | 0.610 |
Why?
|
| Mutation | 20 | 2025 | 6176 | 0.580 |
Why?
|
| Genome, Human | 3 | 2024 | 1332 | 0.560 |
Why?
|
| Databases, Genetic | 8 | 2025 | 500 | 0.550 |
Why?
|
| Genetic Testing | 3 | 2025 | 1098 | 0.510 |
Why?
|
| Germ-Line Mutation | 2 | 2017 | 372 | 0.510 |
Why?
|
| Sequence Analysis, DNA | 2 | 2019 | 1745 | 0.500 |
Why?
|
| Intellectual Disability | 4 | 2025 | 1072 | 0.450 |
Why?
|
| Phosphoric Diester Hydrolases | 2 | 2026 | 70 | 0.450 |
Why?
|
| Genetic Predisposition to Disease | 11 | 2026 | 3411 | 0.430 |
Why?
|
| Open Reading Frames | 1 | 2014 | 200 | 0.420 |
Why?
|
| Genotype | 4 | 2022 | 2655 | 0.420 |
Why?
|
| Genetics, Medical | 1 | 2014 | 119 | 0.410 |
Why?
|
| Exome | 3 | 2024 | 1076 | 0.400 |
Why?
|
| Neurodevelopmental Disorders | 3 | 2025 | 610 | 0.390 |
Why?
|
| Humans | 63 | 2026 | 131501 | 0.360 |
Why?
|
| Calmodulin | 2 | 2024 | 208 | 0.360 |
Why?
|
| Models, Genetic | 7 | 2022 | 751 | 0.350 |
Why?
|
| ROC Curve | 3 | 2025 | 615 | 0.330 |
Why?
|
| Autism Spectrum Disorder | 3 | 2021 | 438 | 0.330 |
Why?
|
| Mitochondrial Proteins | 2 | 2025 | 276 | 0.330 |
Why?
|
| Breast Neoplasms | 5 | 2026 | 2646 | 0.330 |
Why?
|
| Proteins | 4 | 2014 | 1025 | 0.330 |
Why?
|
| Mitochondrial Diseases | 2 | 2025 | 149 | 0.320 |
Why?
|
| Head and Neck Neoplasms | 5 | 2023 | 631 | 0.320 |
Why?
|
| Escherichia coli | 3 | 2023 | 984 | 0.320 |
Why?
|
| Neoplasms | 3 | 2022 | 2969 | 0.270 |
Why?
|
| Chemistry, Physical | 2 | 2007 | 30 | 0.270 |
Why?
|
| Algorithms | 7 | 2024 | 1685 | 0.270 |
Why?
|
| Gene Frequency | 3 | 2025 | 750 | 0.270 |
Why?
|
| Models, Molecular | 8 | 2026 | 1087 | 0.250 |
Why?
|
| Biophysics | 1 | 2006 | 49 | 0.250 |
Why?
|
| Cell Cycle Proteins | 3 | 2019 | 703 | 0.250 |
Why?
|
| Cisplatin | 3 | 2023 | 286 | 0.240 |
Why?
|
| A Kinase Anchor Proteins | 2 | 2018 | 22 | 0.240 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2016 | 758 | 0.230 |
Why?
|
| Cerebroside-Sulfatase | 1 | 2025 | 9 | 0.230 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2025 | 88 | 0.220 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2025 | 106 | 0.220 |
Why?
|
| Ribonucleotides | 1 | 2024 | 31 | 0.220 |
Why?
|
| RNA Stability | 1 | 2024 | 75 | 0.210 |
Why?
|
| Hyperparathyroidism | 1 | 2024 | 24 | 0.210 |
Why?
|
| DNA Replication | 1 | 2026 | 359 | 0.210 |
Why?
|
| Reproducibility of Results | 3 | 2022 | 2985 | 0.210 |
Why?
|
| Genetic Association Studies | 3 | 2017 | 837 | 0.200 |
Why?
|
| Ovarian Neoplasms | 2 | 2019 | 455 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2024 | 195 | 0.200 |
Why?
|
| Selection, Genetic | 3 | 2022 | 157 | 0.190 |
Why?
|
| Protein Stability | 5 | 2024 | 166 | 0.190 |
Why?
|
| DNA | 2 | 2026 | 1442 | 0.190 |
Why?
|
| Software | 2 | 2025 | 752 | 0.190 |
Why?
|
| RNA Splicing | 1 | 2024 | 234 | 0.190 |
Why?
|
| Calculi | 1 | 2022 | 15 | 0.180 |
Why?
|
| Phylogeny | 3 | 2021 | 707 | 0.180 |
Why?
|
| Rare Diseases | 1 | 2024 | 208 | 0.180 |
Why?
|
| Mobile Applications | 1 | 2023 | 114 | 0.180 |
Why?
|
| Nucleic Acids | 1 | 2021 | 26 | 0.180 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2021 | 39 | 0.180 |
Why?
|
| Xanthines | 1 | 2021 | 10 | 0.170 |
Why?
|
| Glycoside Hydrolases | 1 | 2021 | 17 | 0.170 |
Why?
|
| Apraxias | 1 | 2021 | 16 | 0.170 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2025 | 327 | 0.170 |
Why?
|
| Thermodynamics | 3 | 2025 | 147 | 0.170 |
Why?
|
| Lung Neoplasms | 2 | 2025 | 1541 | 0.160 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2020 | 28 | 0.160 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2021 | 129 | 0.160 |
Why?
|
| Acetylglucosaminidase | 1 | 2019 | 12 | 0.160 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2019 | 14 | 0.160 |
Why?
|
| Escherichia coli Proteins | 1 | 2022 | 311 | 0.160 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 135 | 0.150 |
Why?
|
| Yeasts | 1 | 2019 | 42 | 0.150 |
Why?
|
| Antineoplastic Agents | 2 | 2023 | 1809 | 0.150 |
Why?
|
| Checkpoint Kinase 2 | 1 | 2019 | 36 | 0.150 |
Why?
|
| Iron-Binding Proteins | 1 | 2019 | 33 | 0.150 |
Why?
|
| BRCA2 Protein | 1 | 2019 | 55 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2017 | 115 | 0.150 |
Why?
|
| Protein Conformation | 6 | 2019 | 810 | 0.150 |
Why?
|
| Circular Dichroism | 3 | 2025 | 79 | 0.150 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2022 | 391 | 0.150 |
Why?
|
| Sex Factors | 1 | 2023 | 1345 | 0.150 |
Why?
|
| BRCA1 Protein | 1 | 2019 | 83 | 0.150 |
Why?
|
| Computer Simulation | 5 | 2019 | 685 | 0.150 |
Why?
|
| Cell Line, Tumor | 7 | 2024 | 3672 | 0.150 |
Why?
|
| Blood Glucose | 1 | 2023 | 1102 | 0.150 |
Why?
|
| Autoantigens | 1 | 2019 | 104 | 0.150 |
Why?
|
| Phenylalanine-tRNA Ligase | 1 | 2018 | 3 | 0.140 |
Why?
|
| Viral Vaccines | 1 | 2021 | 317 | 0.140 |
Why?
|
| Methyltransferases | 1 | 2019 | 77 | 0.140 |
Why?
|
| Crystallography, X-Ray | 3 | 2026 | 365 | 0.140 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2018 | 26 | 0.140 |
Why?
|
| Phosphorylation | 5 | 2025 | 1569 | 0.140 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 12 | 1 | 2018 | 18 | 0.140 |
Why?
|
| Hepatectomy | 1 | 2019 | 123 | 0.140 |
Why?
|
| Biological Evolution | 2 | 2022 | 229 | 0.140 |
Why?
|
| GTP Phosphohydrolases | 1 | 2019 | 159 | 0.140 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 174 | 0.140 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 566 | 0.140 |
Why?
|
| Sequence Alignment | 1 | 2019 | 595 | 0.140 |
Why?
|
| Anoctamins | 1 | 2017 | 13 | 0.140 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 2 | 2018 | 12 | 0.140 |
Why?
|
| Mitochondria | 2 | 2025 | 759 | 0.140 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2019 | 254 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 5 | 0.130 |
Why?
|
| Pyruvate Kinase | 1 | 2017 | 10 | 0.130 |
Why?
|
| Autistic Disorder | 1 | 2021 | 388 | 0.130 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2023 | 825 | 0.130 |
Why?
|
| Codon | 1 | 2017 | 95 | 0.130 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2018 | 158 | 0.130 |
Why?
|
| Job Syndrome | 1 | 2016 | 18 | 0.130 |
Why?
|
| Area Under Curve | 1 | 2017 | 320 | 0.130 |
Why?
|
| Female | 20 | 2026 | 71086 | 0.120 |
Why?
|
| Schizophrenia | 1 | 2019 | 331 | 0.120 |
Why?
|
| Precision Medicine | 2 | 2019 | 376 | 0.120 |
Why?
|
| Benchmarking | 1 | 2017 | 138 | 0.120 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 432 | 0.120 |
Why?
|
| False Positive Reactions | 1 | 2016 | 142 | 0.120 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2017 | 172 | 0.110 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 875 | 0.110 |
Why?
|
| Antiviral Agents | 1 | 2021 | 812 | 0.110 |
Why?
|
| DNA-Binding Proteins | 2 | 2020 | 1956 | 0.110 |
Why?
|
| Tongue Neoplasms | 1 | 2015 | 31 | 0.110 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2014 | 60 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 1 | 2016 | 233 | 0.110 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2018 | 287 | 0.110 |
Why?
|
| Serine Endopeptidases | 2 | 2014 | 199 | 0.110 |
Why?
|
| Imidazoles | 1 | 2015 | 222 | 0.100 |
Why?
|
| Protein Interaction Mapping | 1 | 2014 | 91 | 0.100 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 711 | 0.100 |
Why?
|
| Morbidity | 1 | 2014 | 258 | 0.100 |
Why?
|
| Piperazines | 1 | 2015 | 272 | 0.100 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2014 | 226 | 0.100 |
Why?
|
| Genetics, Population | 1 | 2014 | 185 | 0.100 |
Why?
|
| Models, Chemical | 3 | 2011 | 81 | 0.100 |
Why?
|
| Nuclear Proteins | 2 | 2020 | 1226 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 1409 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 638 | 0.100 |
Why?
|
| Protein Domains | 2 | 2026 | 249 | 0.090 |
Why?
|
| Monte Carlo Method | 3 | 2007 | 102 | 0.090 |
Why?
|
| Rec A Recombinases | 1 | 2011 | 27 | 0.090 |
Why?
|
| Desmosterol | 1 | 2011 | 3 | 0.090 |
Why?
|
| Carbamoyl-Phosphate Synthase I Deficiency Disease | 1 | 2011 | 6 | 0.090 |
Why?
|
| Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2011 | 9 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2019 | 1612 | 0.090 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 794 | 0.090 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2011 | 30 | 0.090 |
Why?
|
| DNA Mutational Analysis | 2 | 2011 | 803 | 0.080 |
Why?
|
| Hyperammonemia | 1 | 2011 | 61 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 2566 | 0.080 |
Why?
|
| Mice, Nude | 3 | 2018 | 714 | 0.080 |
Why?
|
| Binding Sites | 3 | 2019 | 1202 | 0.080 |
Why?
|
| DNA Copy Number Variations | 1 | 2015 | 1023 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 617 | 0.080 |
Why?
|
| Bacterial Proteins | 2 | 2014 | 943 | 0.080 |
Why?
|
| Ribonucleotide Reductases | 1 | 2009 | 10 | 0.080 |
Why?
|
| Male | 11 | 2025 | 65158 | 0.080 |
Why?
|
| Mitochondrial Encephalomyopathies | 1 | 2009 | 27 | 0.080 |
Why?
|
| Gastrointestinal Motility | 1 | 2009 | 60 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2018 | 4674 | 0.070 |
Why?
|
| Apoptosis | 1 | 2015 | 1861 | 0.070 |
Why?
|
| Child, Preschool | 5 | 2025 | 15047 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 1386 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2014 | 556 | 0.070 |
Why?
|
| Animals | 9 | 2024 | 34335 | 0.070 |
Why?
|
| Structure-Activity Relationship | 2 | 2021 | 579 | 0.070 |
Why?
|
| Myocardium | 1 | 2013 | 874 | 0.070 |
Why?
|
| Adult | 7 | 2026 | 31666 | 0.070 |
Why?
|
| Protein Binding | 3 | 2018 | 1710 | 0.070 |
Why?
|
| DNA, Mitochondrial | 1 | 2009 | 241 | 0.070 |
Why?
|
| Machine Learning | 2 | 2025 | 375 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 1839 | 0.060 |
Why?
|
| Ions | 1 | 2006 | 25 | 0.060 |
Why?
|
| Hydrogen Bonding | 1 | 2006 | 83 | 0.060 |
Why?
|
| Molecular Conformation | 1 | 2006 | 98 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2024 | 403 | 0.060 |
Why?
|
| Solvents | 1 | 2006 | 44 | 0.060 |
Why?
|
| Scattering, Small Angle | 1 | 2026 | 10 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 2355 | 0.060 |
Why?
|
| Temperature | 1 | 2006 | 294 | 0.060 |
Why?
|
| Biological Specimen Banks | 1 | 2026 | 64 | 0.060 |
Why?
|
| Gastrointestinal Diseases | 1 | 2009 | 340 | 0.060 |
Why?
|
| United Kingdom | 1 | 2026 | 254 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 2081 | 0.060 |
Why?
|
| Protein Multimerization | 1 | 2026 | 152 | 0.060 |
Why?
|
| RNA-Binding Motifs | 1 | 2024 | 3 | 0.050 |
Why?
|
| Gene Deletion | 2 | 2018 | 773 | 0.050 |
Why?
|
| Cell Survival | 2 | 2018 | 853 | 0.050 |
Why?
|
| Age of Onset | 1 | 2026 | 631 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2018 | 420 | 0.050 |
Why?
|
| Middle Aged | 5 | 2026 | 28839 | 0.050 |
Why?
|
| Models, Statistical | 1 | 2006 | 492 | 0.050 |
Why?
|
| Adolescent | 4 | 2025 | 20918 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 1001 | 0.050 |
Why?
|
| Mutation Rate | 1 | 2023 | 68 | 0.050 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2023 | 35 | 0.050 |
Why?
|
| HEK293 Cells | 2 | 2018 | 809 | 0.050 |
Why?
|
| Prognosis | 2 | 2024 | 4951 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2024 | 1988 | 0.050 |
Why?
|
| Survival Rate | 2 | 2019 | 2149 | 0.050 |
Why?
|
| Young Adult | 3 | 2025 | 10092 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2023 | 227 | 0.050 |
Why?
|
| Colistin | 1 | 2022 | 31 | 0.050 |
Why?
|
| Adiposity | 1 | 2023 | 207 | 0.050 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2013 | 135 | 0.050 |
Why?
|
| Ciprofloxacin | 1 | 2022 | 67 | 0.050 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2023 | 131 | 0.050 |
Why?
|
| Child | 4 | 2025 | 26240 | 0.040 |
Why?
|
| Pedigree | 1 | 2025 | 1710 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIbeta Subunit | 1 | 2021 | 2 | 0.040 |
Why?
|
| Mice | 4 | 2024 | 18470 | 0.040 |
Why?
|
| Zebrafish | 1 | 2024 | 428 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2024 | 2436 | 0.040 |
Why?
|
| Molecular Docking Simulation | 1 | 2021 | 147 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 2021 | 161 | 0.040 |
Why?
|
| Cystathionine | 1 | 2019 | 5 | 0.040 |
Why?
|
| Proteome | 1 | 2021 | 286 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2021 | 179 | 0.040 |
Why?
|
| Protein Engineering | 1 | 2019 | 62 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2022 | 846 | 0.040 |
Why?
|
| Homocysteine | 1 | 2019 | 118 | 0.040 |
Why?
|
| Fungal Proteins | 1 | 2019 | 132 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2024 | 1024 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2017 | 2462 | 0.040 |
Why?
|
| Glucose | 1 | 2023 | 848 | 0.040 |
Why?
|
| Protein Folding | 1 | 2019 | 215 | 0.040 |
Why?
|
| Insulin | 1 | 2023 | 1145 | 0.040 |
Why?
|
| Aged | 3 | 2024 | 21238 | 0.040 |
Why?
|
| DNA Repair | 1 | 2021 | 562 | 0.030 |
Why?
|
| Pain | 1 | 2021 | 439 | 0.030 |
Why?
|
| Phenylalanine | 1 | 2018 | 126 | 0.030 |
Why?
|
| Paraplegia | 1 | 2018 | 88 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2019 | 773 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2019 | 307 | 0.030 |
Why?
|
| Linear Models | 1 | 2019 | 695 | 0.030 |
Why?
|
| Fructosediphosphates | 1 | 2017 | 3 | 0.030 |
Why?
|
| Allosteric Site | 1 | 2017 | 12 | 0.030 |
Why?
|
| Whole Genome Sequencing | 1 | 2019 | 357 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2018 | 152 | 0.030 |
Why?
|
| United States | 2 | 2026 | 11794 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2018 | 229 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2017 | 61 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2017 | 57 | 0.030 |
Why?
|
| Solutions | 2 | 2007 | 53 | 0.030 |
Why?
|
| Phosphotyrosine | 1 | 2016 | 30 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 2562 | 0.030 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2016 | 21 | 0.030 |
Why?
|
| Crystallization | 2 | 2007 | 83 | 0.030 |
Why?
|
| Diterpenes | 1 | 2016 | 31 | 0.030 |
Why?
|
| Half-Life | 1 | 2016 | 151 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2017 | 152 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2016 | 113 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2016 | 128 | 0.030 |
Why?
|
| Spleen | 1 | 2016 | 256 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 418 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2014 | 82 | 0.030 |
Why?
|
| CDC2 Protein Kinase | 1 | 2014 | 36 | 0.030 |
Why?
|
| Pyrimidinones | 1 | 2014 | 65 | 0.030 |
Why?
|
| Calcium | 1 | 2019 | 1041 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2014 | 239 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2017 | 1069 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 265 | 0.030 |
Why?
|
| Mitosis | 1 | 2014 | 190 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 989 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 934 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2014 | 286 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 2016 | 646 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 460 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 496 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 665 | 0.030 |
Why?
|
| Cricetulus | 1 | 2013 | 88 | 0.030 |
Why?
|
| CHO Cells | 1 | 2013 | 149 | 0.020 |
Why?
|
| Feedback | 1 | 2014 | 148 | 0.020 |
Why?
|
| Cricetinae | 1 | 2013 | 367 | 0.020 |
Why?
|
| Base Sequence | 1 | 2017 | 2782 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 6916 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 647 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2014 | 221 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2019 | 3452 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 1078 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2014 | 358 | 0.020 |
Why?
|
| Obesity | 1 | 2023 | 2379 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 518 | 0.020 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2011 | 9 | 0.020 |
Why?
|
| Age Determination by Skeleton | 1 | 2011 | 11 | 0.020 |
Why?
|
| Risk Factors | 1 | 2026 | 10952 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2014 | 443 | 0.020 |
Why?
|
| DNA Damage | 1 | 2014 | 527 | 0.020 |
Why?
|
| Homologous Recombination | 1 | 2011 | 99 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 1405 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 300 | 0.020 |
Why?
|
| INDEL Mutation | 1 | 2011 | 96 | 0.020 |
Why?
|
| Codon, Nonsense | 1 | 2011 | 141 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 1346 | 0.020 |
Why?
|
| Gene Expression | 1 | 2015 | 1500 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2011 | 127 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 3693 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2017 | 904 | 0.020 |
Why?
|
| Basal Ganglia | 1 | 2009 | 61 | 0.020 |
Why?
|
| Infant | 1 | 2025 | 13300 | 0.020 |
Why?
|
| RNA, Transfer | 1 | 2009 | 69 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2009 | 197 | 0.020 |
Why?
|
| Exons | 1 | 2011 | 768 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2024 | 12937 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2011 | 3911 | 0.020 |
Why?
|
| Pregnancy | 1 | 2021 | 7572 | 0.020 |
Why?
|
| Brain | 2 | 2011 | 3237 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 1313 | 0.020 |
Why?
|
| Transcriptome | 1 | 2015 | 1162 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 2007 | 81 | 0.020 |
Why?
|
| Scattering, Radiation | 1 | 2007 | 51 | 0.020 |
Why?
|
| Bacillus subtilis | 1 | 2007 | 44 | 0.020 |
Why?
|
| Multienzyme Complexes | 1 | 2007 | 77 | 0.020 |
Why?
|
| Genomics | 1 | 2015 | 1624 | 0.020 |
Why?
|
| Phase Transition | 1 | 2006 | 16 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 613 | 0.020 |
Why?
|
| Light | 1 | 2007 | 174 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2006 | 60 | 0.020 |
Why?
|
| Static Electricity | 1 | 2006 | 44 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 1487 | 0.010 |
Why?
|
| Biopsy | 1 | 2009 | 1249 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 1122 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 990 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2011 | 8589 | 0.010 |
Why?
|